SCHEMBL21292693

SCHEMBL21292693

O=C(O)c1ccc(-c2ccc(C=NNC(=S)Nc3ccc([N+](=O)[O-])cc3)o2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 5/20 0.81
KMT2A Q03164 9/20 0.74
MEN1 O00255 8/20 0.74
KDM4E B2RXH2 3/20 0.74
GAA P10253 2/20 0.74
RECQL P46063 1/20 0.74
MAPT P10636 12/20 0.66
TDP1 Q9NUW8 2/20 0.66
HTT P42858 2/20 0.66
PKM P14618 2/20 0.64
NPSR1 Q6W5P4 1/20 0.64
POLB P06746 2/20 0.64
ALDH1A1 P00352 2/20 0.64
NPC1 O15118 1/20 0.64
HSP90AA1 P07900 1/20 0.64
APEX1 P27695 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21309282 0.90 PHGDH (1.00) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292800 0.87 PHGDH (0.75) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292802 0.87 PHGDH (0.75) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL20115434 0.83 PHGDH (0.67) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292697 0.83 PHGDH (0.67) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL20115432 0.80 PHGDH (1.00) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292822 0.80 PHGDH (1.00) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292826 0.79 KDM4E (1.00) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL21292824 0.79 KDM4E (1.00) PHGDHKMT2AMEN1KDM4EGAA
SCHEMBL4323306 0.79 MAPT (1.00) PHGDHKMT2AMEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885KMT2A 1899/4885MEN1 2502/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KMT2A 1899/4885MEN1 2502/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KMT2A 1899/4885MEN1 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.